Company Encyclopedia
View More
name
Neogenomics
NEO.US
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories.
388.09 B
NEO.USMarket value -Rank by Market Cap -/-

Financial Score

16/12/2025 Update
C
Health Care ServicesIndustry
Industry Ranking31/76
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-12.99%D
    • Profit Margin-16.00%D
    • Gross Margin42.84%B
  • Growth ScoreC
    • Revenue YoY10.10%B
    • Net Profit YoY-45.98%D
    • Total Assets YoY-16.23%E
    • Net Assets YoY-7.70%D
  • Cash ScoreC
    • Cash Flow Margin-624.99%E
    • OCF YoY10.10%B
  • Operating ScoreC
    • Turnover0.47C
  • Debt ScoreB
    • Gearing Ratio39.02%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More
    Posts
    View More

    Baidu 3Q25 Quick Interpretation: Third-quarter results basically met guidance and market expectations. This earnings report provides detailed disclosure of AI revenue, aiming to shift market focus fro...